Merck Animal Health Acquires Vence

September 22, 2022

Merck Animal Health (a division of Merck & Co., Inc.) signed a definitive agreement to acquire Vence from its founders and shareholders. The acquisition will expand Merck Animal Health’s animal intelligence and virtual fencing technology portfolio for cattle producers and ranchers, and is expected to close in Q3 2022 subject to customary conditions.

Buyers
Merck Animal Health (Merck & Co., Inc.)
Targets
Vence
Sellers
Vence founders, Vence shareholders
Location
New Jersey, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.